WebMD Health Corp. announces preliminary results of tender offer
WebMD Health Corp. announced today the preliminary results of its tender offer to purchase up to 3,000,000 shares of its common stock at a price of $52.00 per share, which expired at 5:00 pm, New York City time, on September 8, 2010.
GlaxoSmithKline plc today announced that it has commenced its previously announced tender offer to acquire all of the outstanding shares of Human Genome Sciences for US$13.00 per share in cash.